Quality improvement
Interventional Oncology
The National Comprehensive Cancer Network (NCCN) has accepted a recommendation from SIR into its 2026 NCCN Adult Cancer Pain Guidelines. Thank you to Alan Alper Sag, MD, FSIR; Neil J. Resnick, MD, FSIR; J. Dana Dunleavy, MD; Rahul A. Sheth, MD, FSIR, and the Pain Clinical Specialty Council for their work on this important guideline.
More news from SIR
-
Guidewire
![]()
Updated guidelines for adult cancer pain
![]()
NCCN has incorporated an SIR recommendation into its 2026 Adult Cancer Pain Guidelines. View the updated guideline.
-
Guidewire
![]()
VIRTEX measure supports consistent assessment of liver cancer treatment response
![]()
VIRTEX helps IR practices consistently assess liver cancer treatment response and use outcomes data to support quality improvement.
Quality improvement
Practice development
VIRTEX
Clinical data registries
-
Guidewire
![]()
New paper outlines growing role of IR in liver cancer treatment
![]()
Read more on how IRs are playing a growing, cost-efficient role in liver cancer care, according to new JVIR research.
IR research
JVIR
-
Guidewire
![]()
Is your practice visible to the patients and referring providers you want to reach?
![]()
Looking to grow your IR practice? Find healthcare marketing, branding and digital outreach experts in the SIR Vendor Directory to help expand awareness and strengthen referral networks.
-
Guidewire
![]()
SIR 2027 records the most abstracts ever submitted!
![]()
SIR 2027 set a new record with 1,675 abstract submissions. Learn more and explore SIR Foundation award opportunities by Nov. 15.
SIR Annual Scientific Meeting
Continuous education
Featured
-
Guidewire
![]()
Member benefit spotlight: SIR standardized reports
![]()
News description needed
Quality improvement
Practice development
Membership
![]()
More news from SIR
![]()
-
Guidewire
Updated guidelines for adult cancer pain
NCCN has incorporated an SIR recommendation into its 2026 Adult Cancer Pain Guidelines. View the updated guideline.
-
Guidewire
VIRTEX measure supports consistent assessment of liver cancer treatment response
VIRTEX helps IR practices consistently assess liver cancer treatment response and use outcomes data to support quality improvement.
Quality improvement Practice development VIRTEX Clinical data registries -
Guidewire
New paper outlines growing role of IR in liver cancer treatment
Read more on how IRs are playing a growing, cost-efficient role in liver cancer care, according to new JVIR research.
IR research JVIR -
Guidewire
Is your practice visible to the patients and referring providers you want to reach?
Looking to grow your IR practice? Find healthcare marketing, branding and digital outreach experts in the SIR Vendor Directory to help expand awareness and strengthen referral networks.
-
Guidewire
SIR 2027 records the most abstracts ever submitted!
SIR 2027 set a new record with 1,675 abstract submissions. Learn more and explore SIR Foundation award opportunities by Nov. 15.
SIR Annual Scientific Meeting Continuous education Featured -
Guidewire
Member benefit spotlight: SIR standardized reports
News description needed
Quality improvement Practice development Membership
More news from SIR